$IMMU Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in IMMUNOMEDICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in IMMUNOMEDICS INC. Get notifications about new insider transactions in IMMUNOMEDICS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 23 2020 | IMMU | IMMUNOMEDICS INC | Malik Usama | Chief Fin. & Busine ... | Option Exercise | D | 0.00 | 386,080 | 0 | 0 | |
Oct 23 2020 | IMMU | IMMUNOMEDICS INC | Malik Usama | Chief Fin. & Busine ... | Sell | D | 0.00 | 18,856 | 0 | 0 | 18.9 K to 0 (-100.00 %) |
Oct 23 2020 | IMMU | IMMUNOMEDICS INC | ITRI LORETTTA M | Chief Medical Offic ... | Option Exercise | D | 0.00 | 200,000 | 0 | 0 | |
Oct 23 2020 | IMMU | IMMUNOMEDICS INC | ITRI LORETTTA M | Chief Medical Offic ... | Sell | D | 0.00 | 15,000 | 0 | 0 | 15 K to 0 (-100.00 %) |
Oct 23 2020 | IMMU | IMMUNOMEDICS INC | Andrews Kurt J. | Chief Human Resourc ... | Option Exercise | D | 0.00 | 238,072 | 0 | 0 | |
Oct 23 2020 | IMMU | IMMUNOMEDICS INC | Islam Khalid | Director | Option Exercise | D | 0.00 | 3,718 | 0 | 0 | |
Oct 23 2020 | IMMU | IMMUNOMEDICS INC | Islam Khalid | Director | Option Exercise | D | 0.00 | 52,614 | 0 | 0 | |
Oct 23 2020 | IMMU | IMMUNOMEDICS INC | Islam Khalid | Director | Sell | D | 0.00 | 13,516 | 0 | 0 | 13.5 K to 0 (-100.00 %) |
Oct 23 2020 | IMMU | IMMUNOMEDICS INC | BALL BRYAN | Chief Quality Offic ... | Option Exercise | D | 0.00 | 261,937 | 0 | 0 | |
Oct 23 2020 | IMMU | IMMUNOMEDICS INC | BALL BRYAN | Chief Quality Offic ... | Sell | D | 0.00 | 10,000 | 0 | 0 | 10 K to 0 (-100.00 %) |
Oct 23 2020 | IMMU | IMMUNOMEDICS INC | Freedberg Jared | Gen. Counsel & Corp ... | Option Exercise | D | 0.00 | 280,105 | 0 | 0 | |
Oct 23 2020 | IMMU | IMMUNOMEDICS INC | Delaney Brendan | Chief Commercial Of ... | Option Exercise | D | 0.00 | 390,460 | 0 | 0 | |
Oct 23 2020 | IMMU | IMMUNOMEDICS INC | BAUM CHARLES M | Director | Option Exercise | D | 0.00 | 3,718 | 0 | 0 | |
Oct 23 2020 | IMMU | IMMUNOMEDICS INC | BAUM CHARLES M | Director | Option Exercise | D | 0.00 | 46,117 | 0 | 0 | |
Oct 23 2020 | IMMU | IMMUNOMEDICS INC | BAUM CHARLES M | Director | Sell | D | 0.00 | 9,667 | 0 | 0 | 9.7 K to 0 (-100.00 %) |
Oct 23 2020 | IMMU | IMMUNOMEDICS INC | Duncan Barbara Gayle | Director | Option Exercise | D | 0.00 | 3,718 | 0 | 0 | |
Oct 23 2020 | IMMU | IMMUNOMEDICS INC | Duncan Barbara Gayle | Director | Option Exercise | D | 0.00 | 6,540 | 0 | 0 | |
Oct 23 2020 | IMMU | IMMUNOMEDICS INC | Duncan Barbara Gayle | Director | Sell | D | 0.00 | 49,244 | 0 | 0 | 49.2 K to 0 (-100.00 %) |
Sep 15 2020 | IMMU | IMMUNOMEDICS INC | Duncan Barbara Gayle | Director | Option Exercise | M | 16.96 | 2,500 | 42,400 | 0 | |
Sep 15 2020 | IMMU | IMMUNOMEDICS INC | Duncan Barbara Gayle | Director | Buy | M | 16.96 | 2,500 | 42,400 | 39,577 | 37.1 K to 39.6 K (+6.74 %) |
Aug 20 2020 | IMMU | IMMUNOMEDICS INC | Duncan Barbara Gayle | Director | Option Exercise | M | 16.96 | 20,000 | 339,200 | 0 | |
Aug 20 2020 | IMMU | IMMUNOMEDICS INC | Duncan Barbara Gayle | Director | Buy | M | 16.96 | 20,000 | 339,200 | 37,077 | 17.1 K to 37.1 K (+117.12 %) |
Aug 14 2020 | IMMU | IMMUNOMEDICS INC | Duncan Barbara Gayle | Director | Option Exercise | M | 12.93 | 17,077 | 220,806 | 0 | |
Aug 14 2020 | IMMU | IMMUNOMEDICS INC | Duncan Barbara Gayle | Director | Buy | M | 12.93 | 17,077 | 220,806 | 17,077 | 0 to 17.1 K |
Jun 22 2020 | IMMU | IMMUNOMEDICS INC | Aghazadeh Behzad | Director | Option Exercise | A | 33.62 | 6,540 | 219,875 | 6,540 | |
Jun 22 2020 | IMMU | IMMUNOMEDICS INC | Aghazadeh Behzad | Director | Grant | A | 0.00 | 3,718 | 0 | 17,234 | 13.5 K to 17.2 K (+27.51 %) |
Jun 22 2020 | IMMU | IMMUNOMEDICS INC | BAUM CHARLES M | Director | Option Exercise | A | 33.62 | 6,540 | 219,875 | 6,540 | |
Jun 22 2020 | IMMU | IMMUNOMEDICS INC | BAUM CHARLES M | Director | Grant | A | 0.00 | 3,718 | 0 | 13,385 | 9.7 K to 13.4 K (+38.46 %) |
Jun 22 2020 | IMMU | IMMUNOMEDICS INC | HUTT PETER BARTON | Director | Option Exercise | A | 33.62 | 6,540 | 219,875 | 6,540 | |
Jun 22 2020 | IMMU | IMMUNOMEDICS INC | HUTT PETER BARTON | Director | Grant | A | 0.00 | 3,718 | 0 | 17,234 | 13.5 K to 17.2 K (+27.51 %) |
Jun 22 2020 | IMMU | IMMUNOMEDICS INC | Islam Khalid | Director | Option Exercise | A | 33.62 | 6,540 | 219,875 | 6,540 | |
Jun 22 2020 | IMMU | IMMUNOMEDICS INC | Islam Khalid | Director | Grant | A | 0.00 | 3,718 | 0 | 17,234 | 13.5 K to 17.2 K (+27.51 %) |
Jun 22 2020 | IMMU | IMMUNOMEDICS INC | Duncan Barbara Gayle | Director | Option Exercise | A | 33.62 | 6,540 | 219,875 | 6,540 | |
Jun 22 2020 | IMMU | IMMUNOMEDICS INC | Duncan Barbara Gayle | Director | Grant | A | 0.00 | 3,718 | 0 | 13,385 | 9.7 K to 13.4 K (+38.46 %) |
Jun 22 2020 | IMMU | IMMUNOMEDICS INC | Canute Scott A | Director | Option Exercise | A | 33.62 | 6,540 | 219,875 | 6,540 | |
Jun 22 2020 | IMMU | IMMUNOMEDICS INC | Canute Scott A | Director | Grant | A | 0.00 | 3,718 | 0 | 17,234 | 13.5 K to 17.2 K (+27.51 %) |
Jun 22 2020 | IMMU | IMMUNOMEDICS INC | Azelby Robert | Director | Option Exercise | A | 33.62 | 6,540 | 219,875 | 6,540 | |
Jun 22 2020 | IMMU | IMMUNOMEDICS INC | Azelby Robert | Director | Grant | A | 0.00 | 3,718 | 0 | 3,718 | 0 to 3.7 K |
May 01 2020 | IMMU | IMMUNOMEDICS INC | Avoro Capital Advisors LLC | Director | Buy | P | 28.50 | 1,750,000 | 49,875,000 | 26,250,000 | 24.5 M to 26.3 M (+7.14 %) |
Apr 20 2020 | IMMU | IMMUNOMEDICS INC | Semerjian Harout | President and CEO | Option Exercise | A | 19.97 | 252,602 | 5,044,462 | 252,602 | |
Apr 20 2020 | IMMU | IMMUNOMEDICS INC | Semerjian Harout | President and CEO | Grant | A | 0.00 | 50,075 | 0 | 50,075 | 0 to 50.1 K |
Mar 20 2020 | IMMU | IMMUNOMEDICS INC | Aghazadeh Behzad | Director | Grant | A | 0.00 | 100,000 | 0 | 100,000 | 0 to 100 K |
Mar 20 2020 | IMMU | IMMUNOMEDICS INC | Aghazadeh Behzad | Director | Grant | A | 0.00 | 100,000 | 0 | 100,000 | 0 to 100 K |
Mar 05 2020 | IMMU | IMMUNOMEDICS INC | Delaney Brendan | Chief Commerical Of ... | Option Exercise | A | 17.16 | 51,600 | 885,456 | 51,600 | |
Mar 05 2020 | IMMU | IMMUNOMEDICS INC | BALL BRYAN | Chief Quality Offic ... | Option Exercise | A | 17.16 | 51,600 | 885,456 | 51,600 | |
Mar 05 2020 | IMMU | IMMUNOMEDICS INC | Andrews Kurt J. | Chief Human Resourc ... | Option Exercise | A | 17.16 | 51,600 | 885,456 | 51,600 | |
Mar 05 2020 | IMMU | IMMUNOMEDICS INC | Malik Usama | Chief Business Offi ... | Option Exercise | A | 17.16 | 61,920 | 1,062,547 | 61,920 | |
Mar 05 2020 | IMMU | IMMUNOMEDICS INC | Freedberg Jared | General Counsel | Option Exercise | A | 17.16 | 51,600 | 885,456 | 51,600 | |
Feb 27 2020 | IMMU | IMMUNOMEDICS INC | Azelby Robert | Director | Option Exercise | A | 16.36 | 22,500 | 368,100 | 22,500 | |
Feb 18 2020 | IMMU | IMMUNOMEDICS INC | ITRI LORETTTA M | Chief Medical Offic ... | Option Exercise | A | 18.76 | 130,000 | 2,438,800 | 130,000 | |
Dec 09 2019 | IMMU | IMMUNOMEDICS INC | Avoro Capital Advisors LLC | Director | Buy | P | 17.50 | 2,000,000 | 35,000,000 | 24,500,000 | 22.5 M to 24.5 M (+8.89 %) |
Nov 20 2019 | IMMU | IMMUNOMEDICS INC | Aghazadeh Behzad | Director | Option Exercise | A | 18.74 | 150,000 | 2,811,000 | 150,000 | |
Oct 04 2019 | IMMU | IMMUNOMEDICS INC | Avoro Capital Advisors LLC | Director | Buy | P | 14.10 | 500,000 | 7,050,000 | 22,500,000 | 22 M to 22.5 M (+2.27 %) |
Oct 04 2019 | IMMU | IMMUNOMEDICS INC | Avoro Capital Advisors LLC | Director | Buy | P | 13.23 | 1,000,000 | 13,230,000 | 22,000,000 | 21 M to 22 M (+4.76 %) |
Oct 03 2019 | IMMU | IMMUNOMEDICS INC | BALL BRYAN | Chief Quality Offic ... | Buy | P | 14.18 | 5,000 | 70,897 | 10,000 | 5 K to 10 K (+100.00 %) |
Sep 10 2019 | IMMU | IMMUNOMEDICS INC | Delaney Brendan | Chief Commercial Of ... | Option Exercise | A | 13.19 | 67,480 | 890,061 | 67,480 | |
Sep 10 2019 | IMMU | IMMUNOMEDICS INC | Malik Usama | Chief Business Offi ... | Option Exercise | A | 13.19 | 79,480 | 1,048,341 | 79,480 | |
Sep 10 2019 | IMMU | IMMUNOMEDICS INC | Freedberg Jared | General Counsel | Option Exercise | A | 13.19 | 67,480 | 890,061 | 67,480 | |
Sep 10 2019 | IMMU | IMMUNOMEDICS INC | Fricker William | Principal Accountin ... | Option Exercise | A | 13.19 | 16,870 | 222,515 | 16,870 | |
Sep 10 2019 | IMMU | IMMUNOMEDICS INC | Andrews Kurt J. | Chief Human Resourc ... | Option Exercise | A | 13.19 | 67,480 | 890,061 | 67,480 | |
Sep 10 2019 | IMMU | IMMUNOMEDICS INC | ROSENBERG MORRIS | Chief Technology Of ... | Option Exercise | A | 13.19 | 67,480 | 890,061 | 67,480 | |
Sep 10 2019 | IMMU | IMMUNOMEDICS INC | BALL BRYAN | Chief Quality Offic ... | Option Exercise | A | 15.59 | 10,440 | 162,760 | 10,440 | |
Sep 10 2019 | IMMU | IMMUNOMEDICS INC | BALL BRYAN | Chief Quality Offic ... | Option Exercise | A | 13.19 | 57,040 | 752,358 | 57,040 | |
Jun 28 2019 | IMMU | IMMUNOMEDICS INC | Avoro Capital Advisors LLC | Director | Buy | P | 13.84 | 250,000 | 3,460,000 | 21,000,000 | 20.8 M to 21 M (+1.20 %) |
Jun 28 2019 | IMMU | IMMUNOMEDICS INC | Avoro Capital Advisors LLC | Director | Buy | P | 13.68 | 350,000 | 4,788,000 | 20,750,000 | 20.4 M to 20.8 M (+1.72 %) |
Jun 28 2019 | IMMU | IMMUNOMEDICS INC | Avoro Capital Advisors LLC | Director | Buy | P | 13.25 | 400,000 | 5,300,000 | 20,400,000 | 20 M to 20.4 M (+2.00 %) |
Jun 21 2019 | IMMU | IMMUNOMEDICS INC | BALL BRYAN | Chief Quality Offic ... | Buy | P | 13.35 | 5,000 | 66,750 | 5,000 | 0 to 5 K |
Jun 11 2019 | IMMU | IMMUNOMEDICS INC | Aghazadeh Behzad | Director | Option Exercise | A | 12.93 | 17,077 | 220,806 | 17,077 | |
Jun 11 2019 | IMMU | IMMUNOMEDICS INC | Aghazadeh Behzad | Director | Grant | A | 0.00 | 9,667 | 0 | 13,516 | 3.8 K to 13.5 K (+251.16 %) |
Jun 11 2019 | IMMU | IMMUNOMEDICS INC | Islam Khalid | Director | Option Exercise | A | 12.93 | 17,077 | 220,806 | 17,077 | |
Jun 11 2019 | IMMU | IMMUNOMEDICS INC | Islam Khalid | Director | Grant | A | 0.00 | 9,667 | 0 | 13,516 | 3.8 K to 13.5 K (+251.16 %) |
Jun 11 2019 | IMMU | IMMUNOMEDICS INC | Duncan Barbara Gayle | Director | Option Exercise | A | 12.93 | 17,077 | 220,806 | 17,077 | |
Jun 11 2019 | IMMU | IMMUNOMEDICS INC | Duncan Barbara Gayle | Director | Grant | A | 0.00 | 9,667 | 0 | 9,667 | 0 to 9.7 K |
Jun 11 2019 | IMMU | IMMUNOMEDICS INC | HUTT PETER BARTON | Director | Option Exercise | A | 12.93 | 17,077 | 220,806 | 17,077 | |
Jun 11 2019 | IMMU | IMMUNOMEDICS INC | HUTT PETER BARTON | Director | Grant | A | 0.00 | 9,667 | 0 | 13,516 | 3.8 K to 13.5 K (+251.16 %) |
Jun 11 2019 | IMMU | IMMUNOMEDICS INC | Canute Scott A | Director | Option Exercise | A | 12.93 | 17,077 | 220,806 | 17,077 | |
Jun 11 2019 | IMMU | IMMUNOMEDICS INC | Canute Scott A | Director | Grant | A | 0.00 | 9,667 | 0 | 13,516 | 3.8 K to 13.5 K (+251.16 %) |
Jun 11 2019 | IMMU | IMMUNOMEDICS INC | BAUM CHARLES M | Director | Option Exercise | A | 12.93 | 17,077 | 220,806 | 17,077 | |
Jun 11 2019 | IMMU | IMMUNOMEDICS INC | BAUM CHARLES M | Director | Grant | A | 0.00 | 9,667 | 0 | 9,667 | 0 to 9.7 K |
Jun 05 2019 | IMMU | IMMUNOMEDICS INC | Avoro Capital Advisors LLC | Director | Buy | P | 12.47 | 250,000 | 3,117,500 | 20,000,000 | 19.8 M to 20 M (+1.27 %) |
Jun 05 2019 | IMMU | IMMUNOMEDICS INC | Avoro Capital Advisors LLC | Director | Buy | P | 12.10 | 500,000 | 6,050,000 | 19,750,000 | 19.3 M to 19.8 M (+2.60 %) |
Jun 05 2019 | IMMU | IMMUNOMEDICS INC | Avoro Capital Advisors LLC | Director | Buy | P | 12.19 | 785,539 | 9,575,720 | 19,250,000 | 18.5 M to 19.3 M (+4.25 %) |
May 15 2019 | IMMU | IMMUNOMEDICS INC | Avoro Capital Advisors LLC | Director | Buy | P | 14.95 | 125,000 | 1,868,750 | 18,464,461 | 18.3 M to 18.5 M (+0.68 %) |
May 15 2019 | IMMU | IMMUNOMEDICS INC | Avoro Capital Advisors LLC | Director | Buy | P | 15.40 | 125,000 | 1,925,000 | 18,339,461 | 18.2 M to 18.3 M (+0.69 %) |
May 15 2019 | IMMU | IMMUNOMEDICS INC | Avoro Capital Advisors LLC | Director | Buy | P | 15.07 | 500,000 | 7,535,000 | 18,214,461 | 17.7 M to 18.2 M (+2.82 %) |
Apr 04 2019 | IMMU | IMMUNOMEDICS INC | Fricker William | Principal Accountin ... | Option Exercise | A | 17.87 | 15,000 | 268,050 | 15,000 | |
Mar 18 2019 | IMMU | IMMUNOMEDICS INC | Delaney Brendan | CHIEF COMMERCIAL OF ... | Option Exercise | A | 17.94 | 25,660 | 460,340 | 25,660 | |
Mar 18 2019 | IMMU | IMMUNOMEDICS INC | Delaney Brendan | CHIEF COMMERCIAL OF ... | Option Exercise | A | 17.94 | 51,320 | 920,681 | 51,320 | |
Mar 18 2019 | IMMU | IMMUNOMEDICS INC | Malik Usama | Chief Financial & B ... | Option Exercise | A | 17.94 | 25,660 | 460,340 | 25,660 | |
Mar 18 2019 | IMMU | IMMUNOMEDICS INC | Malik Usama | Chief Financial & B ... | Option Exercise | A | 17.94 | 51,320 | 920,681 | 51,320 | |
Mar 18 2019 | IMMU | IMMUNOMEDICS INC | Iannone Robert | CHIEF MEDICAL OFFIC ... | Option Exercise | A | 17.94 | 25,660 | 460,340 | 25,660 | |
Mar 18 2019 | IMMU | IMMUNOMEDICS INC | Iannone Robert | CHIEF MEDICAL OFFIC ... | Option Exercise | A | 17.94 | 51,230 | 919,066 | 51,230 | |
Mar 18 2019 | IMMU | IMMUNOMEDICS INC | Fricker William | PRINCIPAL ACCOUNTIN ... | Option Exercise | A | 17.94 | 4,280 | 76,783 | 4,280 | |
Mar 18 2019 | IMMU | IMMUNOMEDICS INC | Fricker William | PRINCIPAL ACCOUNTIN ... | Option Exercise | A | 17.94 | 8,560 | 153,566 | 8,560 | |
Mar 18 2019 | IMMU | IMMUNOMEDICS INC | Freedberg Jared | GENERAL COUNSEL | Option Exercise | A | 17.94 | 13,780 | 247,213 | 13,780 | |
Mar 18 2019 | IMMU | IMMUNOMEDICS INC | Freedberg Jared | GENERAL COUNSEL | Option Exercise | A | 17.94 | 27,560 | 494,426 | 27,560 | |
Mar 18 2019 | IMMU | IMMUNOMEDICS INC | ROSENBERG MORRIS | CHIEF TECHNOLOGY OF ... | Option Exercise | A | 17.94 | 25,000 | 448,500 | 25,000 | |
Mar 18 2019 | IMMU | IMMUNOMEDICS INC | ROSENBERG MORRIS | CHIEF TECHNOLOGY OF ... | Option Exercise | A | 17.94 | 42,760 | 767,114 | 42,760 | |
Mar 18 2019 | IMMU | IMMUNOMEDICS INC | Andrews Kurt J. | CHIEF HUMAN RESOURC ... | Option Exercise | A | 17.94 | 14,260 | 255,824 | 14,260 | |
Mar 18 2019 | IMMU | IMMUNOMEDICS INC | Andrews Kurt J. | CHIEF HUMAN RESOURC ... | Option Exercise | A | 17.94 | 28,510 | 511,469 | 28,510 | |
Mar 11 2019 | IMMU | IMMUNOMEDICS INC | Canute Scott A | Director | Option Exercise | A | 16.35 | 22,854 | 373,663 | 22,854 | |
Mar 11 2019 | IMMU | IMMUNOMEDICS INC | Canute Scott A | Director | Option Exercise | A | 16.96 | 79,818 | 1,353,713 | 79,818 | |
Mar 07 2019 | IMMU | IMMUNOMEDICS INC | Duncan Barbara Gayle | Director | Option Exercise | A | 16.96 | 22,500 | 381,600 | 22,500 | |
Mar 07 2019 | IMMU | IMMUNOMEDICS INC | BALL BRYAN | Chief Quality Offic ... | Option Exercise | A | 16.96 | 142,857 | 2,422,855 | 142,857 | |
Feb 26 2019 | IMMU | IMMUNOMEDICS INC | BAUM CHARLES M | Director | Option Exercise | A | 14.89 | 22,500 | 335,025 | 22,500 | |
Sep 26 2018 | IMMU | IMMUNOMEDICS INC | Freedberg Jared | GENERAL COUNSEL | Option Exercise | A | 21.72 | 119,685 | 2,599,558 | 119,685 | |
Sep 19 2018 | IMMU | IMMUNOMEDICS INC | Islam Khalid | Director | Option Exercise | A | 14.29 | 6,497 | 92,842 | 6,497 | |
Sep 19 2018 | IMMU | IMMUNOMEDICS INC | Islam Khalid | Director | Grant | A | 0.00 | 3,849 | 0 | 3,849 | 0 to 3.8 K |
Sep 18 2018 | IMMU | IMMUNOMEDICS INC | Aghazadeh Behzad | Director | Option Exercise | A | 14.29 | 6,497 | 92,842 | 6,497 | |
Sep 18 2018 | IMMU | IMMUNOMEDICS INC | Aghazadeh Behzad | Director | Grant | A | 0.00 | 3,849 | 0 | 3,849 | 0 to 3.8 K |
Sep 18 2018 | IMMU | IMMUNOMEDICS INC | Fricker William | Principal Accountin ... | Option Exercise | A | 22.27 | 5,600 | 124,712 | 5,600 | |
Sep 18 2018 | IMMU | IMMUNOMEDICS INC | Delaney Brendan | Chief Commercial Of ... | Option Exercise | A | 22.27 | 44,400 | 988,788 | 44,400 | |
Sep 18 2018 | IMMU | IMMUNOMEDICS INC | Malik Usama | See Remarks | Option Exercise | A | 22.27 | 67,700 | 1,507,679 | 67,700 | |
Sep 18 2018 | IMMU | IMMUNOMEDICS INC | Iannone Robert | Chief Medical Offic ... | Option Exercise | A | 22.27 | 15,900 | 354,093 | 15,900 | |
Sep 18 2018 | IMMU | IMMUNOMEDICS INC | Canute Scott A | Director | Option Exercise | A | 14.29 | 6,497 | 92,842 | 6,497 | |
Sep 18 2018 | IMMU | IMMUNOMEDICS INC | Canute Scott A | Director | Grant | A | 0.00 | 3,849 | 0 | 3,849 | 0 to 3.8 K |
Sep 18 2018 | IMMU | IMMUNOMEDICS INC | HUTT PETER BARTON | Director | Option Exercise | A | 14.29 | 6,497 | 92,842 | 6,497 | |
Sep 18 2018 | IMMU | IMMUNOMEDICS INC | HUTT PETER BARTON | Director | Grant | A | 0.00 | 3,849 | 0 | 3,849 | 0 to 3.8 K |
Sep 18 2018 | IMMU | IMMUNOMEDICS INC | PEHL MICHAEL F. | President and CEO | Option Exercise | A | 22.27 | 81,800 | 1,821,686 | 81,800 | |
Sep 18 2018 | IMMU | IMMUNOMEDICS INC | ROSENBERG MORRIS | Chief Technology Of ... | Option Exercise | A | 22.27 | 37,300 | 830,671 | 37,300 | |
Jun 19 2018 | IMMU | IMMUNOMEDICS INC | venBio Select Advisor LLC | Director | Buy | P | 23.39 | 200,000 | 4,678,000 | 17,714,461 | 17.5 M to 17.7 M (+1.14 %) |
Jun 15 2018 | IMMU | IMMUNOMEDICS INC | venBio Select Advisor LLC | Director | Buy | P | 24.00 | 575,000 | 13,800,000 | 17,514,461 | 16.9 M to 17.5 M (+3.39 %) |
Mar 12 2018 | IMMU | IMMUNOMEDICS INC | GOLDENBERG DAVID M | Director | Sell | S | 17.75 | 20,000 | 355,000 | 5,613,252 | 5.6 M to 5.6 M (-0.36 %) |
Mar 12 2018 | IMMU | IMMUNOMEDICS INC | GOLDENBERG DAVID M | Director | Sell | S | 17.60 | 20,000 | 352,000 | 5,633,252 | 5.7 M to 5.6 M (-0.35 %) |
Mar 12 2018 | IMMU | IMMUNOMEDICS INC | GOLDENBERG DAVID M | Director | Sell | S | 17.17 | 20,000 | 343,400 | 5,653,252 | 5.7 M to 5.7 M (-0.35 %) |
Mar 12 2018 | IMMU | IMMUNOMEDICS INC | GOLDENBERG DAVID M | Director | Sell | S | 17.30 | 20,000 | 346,000 | 5,673,252 | 5.7 M to 5.7 M (-0.35 %) |
Mar 12 2018 | IMMU | IMMUNOMEDICS INC | GOLDENBERG DAVID M | Director | Sell | S | 17.09 | 17,729 | 302,989 | 5,693,252 | 5.7 M to 5.7 M (-0.31 %) |
Mar 12 2018 | IMMU | IMMUNOMEDICS INC | GOLDENBERG DAVID M | Director | Sell | S | 17.50 | 20,000 | 350,000 | 1,774,285 | 1.8 M to 1.8 M (-1.11 %) |
Feb 16 2018 | IMMU | IMMUNOMEDICS INC | venBio Select Advisor LLC | Director | Option Exercise | E | 7.00 | 1,250 | 8,750 | 0 | |
Feb 16 2018 | IMMU | IMMUNOMEDICS INC | venBio Select Advisor LLC | Director | Option Exercise | X | 7.00 | 1,250 | 8,750 | 0 | |
Feb 16 2018 | IMMU | IMMUNOMEDICS INC | venBio Select Advisor LLC | Director | Option Exercise | E | 7.00 | 2,500 | 17,500 | 0 | |
Feb 16 2018 | IMMU | IMMUNOMEDICS INC | venBio Select Advisor LLC | Director | Option Exercise | X | 7.00 | 2,500 | 17,500 | 0 | |
Feb 16 2018 | IMMU | IMMUNOMEDICS INC | venBio Select Advisor LLC | Director | Option Exercise | E | 7.00 | 5,000 | 35,000 | 0 | |
Feb 16 2018 | IMMU | IMMUNOMEDICS INC | venBio Select Advisor LLC | Director | Option Exercise | X | 7.00 | 5,000 | 35,000 | 0 | |
Feb 16 2018 | IMMU | IMMUNOMEDICS INC | venBio Select Advisor LLC | Director | Buy | X | 7.00 | 875,000 | 6,125,000 | 16,939,461 | 16.1 M to 16.9 M (+5.45 %) |
Dec 11 2017 | IMMU | IMMUNOMEDICS INC | PEHL MICHAEL F. | President and CEO | Option Exercise | A | 11.86 | 1,500,000 | 17,790,000 | 1,500,000 | |
Dec 11 2017 | IMMU | IMMUNOMEDICS INC | PEHL MICHAEL F. | President and CEO | Option Exercise | A | 11.86 | 750,000 | 8,895,000 | 750,000 | |
Nov 21 2017 | IMMU | IMMUNOMEDICS INC | MARKISON BRIAN A | Director | Option Exercise | M | 3.16 | 15,000 | 47,400 | 0 | |
Nov 21 2017 | IMMU | IMMUNOMEDICS INC | MARKISON BRIAN A | Director | Sell | S | 11.89 | 8,390 | 99,724 | 90,788 | 99.2 K to 90.8 K (-8.46 %) |
Nov 21 2017 | IMMU | IMMUNOMEDICS INC | MARKISON BRIAN A | Director | Buy | M | 3.16 | 15,000 | 47,400 | 99,178 | 84.2 K to 99.2 K (+17.82 %) |
Nov 16 2017 | IMMU | IMMUNOMEDICS INC | venBio Select Advisor LLC | Director | Buy | P | 10.97 | 175,000 | 1,919,750 | 16,064,461 | 15.9 M to 16.1 M (+1.10 %) |
Nov 16 2017 | IMMU | IMMUNOMEDICS INC | venBio Select Advisor LLC | Director | Buy | P | 10.39 | 1,150,000 | 11,948,500 | 15,889,461 | 14.7 M to 15.9 M (+7.80 %) |
Nov 15 2017 | IMMU | IMMUNOMEDICS INC | Aghazadeh Behzad | Director | Buy | P | 10.97 | 175,000 | 1,919,750 | 16,064,461 | 15.9 M to 16.1 M (+1.10 %) |
Nov 15 2017 | IMMU | IMMUNOMEDICS INC | Aghazadeh Behzad | Director | Buy | P | 10.39 | 1,150,000 | 11,948,500 | 15,889,461 | 14.7 M to 15.9 M (+7.80 %) |
Nov 14 2017 | IMMU | IMMUNOMEDICS INC | Delaney Brendan | Chief Commercial Of ... | Option Exercise | A | 12.40 | 150,000 | 1,860,000 | 150,000 | |
Oct 12 2017 | IMMU | IMMUNOMEDICS INC | Aghazadeh Behzad | Director | Option Exercise | C | 5.41 | 184,000 | 995,440 | 0 | |
Oct 12 2017 | IMMU | IMMUNOMEDICS INC | Aghazadeh Behzad | Director | Buy | C | 0.00 | 4,251,386 | 0 | 14,739,462 | 10.5 M to 14.7 M (+40.54 %) |
Sep 05 2017 | IMMU | IMMUNOMEDICS INC | GOLDENBERG CYNTHIA L | Director | Sell | S | 12.90 | 10,000 | 129,000 | 778,219 | 788.2 K to 778.2 K (-1.27 %) |
Sep 05 2017 | IMMU | IMMUNOMEDICS INC | GOLDENBERG CYNTHIA L | Director | Sell | S | 12.50 | 5,000 | 62,500 | 788,219 | 793.2 K to 788.2 K (-0.63 %) |
Sep 05 2017 | IMMU | IMMUNOMEDICS INC | GOLDENBERG CYNTHIA L | Director | Sell | S | 12.25 | 5,000 | 61,250 | 793,219 | 798.2 K to 793.2 K (-0.63 %) |